<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is a group of <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> clonal diseases characterized by ineffective hematopoiesis, peripheral blood cytopenias and high risk of transformation to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>.Recently more and more investigations indicate that the abnormality of bone marrow microenvironment is one of important reasons related to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this article the abnormality of stroma cells, cytokines and signaling pathways in hematopoietic micro-environment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is reviewed </plain></SENT>
</text></document>